REVEAL III: Risk Evaluation and Education for Alzheimer's Disease (REVEAL)

Clinical Trial ID NCT00462917

Rank	Title	Journal	Year	PubWeight™‹?›
1	Who seeks genetic susceptibility testing for Alzheimer's disease? Findings from a multisite, randomized clinical trial.	Genet Med	2004	2.44
2	Genetic risk assessment for adult children of people with Alzheimer's disease: the Risk Evaluation and Education for Alzheimer's Disease (REVEAL) study.	J Geriatr Psychiatry Neurol	2005	2.03
3	Reasons for seeking genetic susceptibility testing among first-degree relatives of people with Alzheimer disease.	Alzheimer Dis Assoc Disord	2003	1.79
4	Disclosing Pleiotropic Effects During Genetic Risk Assessment for Alzheimer Disease: A Randomized Trial.	Ann Intern Med	2016	1.47
5	Using Alzheimer's disease as a model for genetic risk disclosure: implications for personal genomics.	Clin Genet	2011	1.34
6	Genetic susceptibility testing versus family history-based risk assessment: Impact on perceived risk of Alzheimer disease.	Genet Med	2005	1.17
7	Differences between African Americans and Whites in their attitudes toward genetic testing for Alzheimer's disease.	Genet Test	2003	1.16
8	Associations between self-referral and health behavior responses to genetic risk information.	Genome Med	2015	0.76